SiRNA targeting HOTAIR has been shown to suppress the progression of endometrial carcinoma in vivo, demonstrating that targeting HOTAIR can be a novel therapeutic strategy for endometrial cancer (164). Here, HOTAIR is linked to endometrial cancer.